---
title: "In the first half of the year, Kangsheng Medical Group's losses narrowed to 10.25 million yuan | Lianhe Zaobao"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275593622.md"
description: "Thomson Medical Group reported a loss of SGD 10.25 million in the first half of the 2026 fiscal year, a decrease from the loss of SGD 12.90 million in the previous year. At the same time, revenue increased by 7% year-on-year to SGD 21.308 million. The group released its earnings report after the market closed on Wednesday (February 11), indicating that the revenue growth was mainly due to increased income from its Singapore operations and contributions from its Malaysia oncology center. During this period, the number of consultations in Vietnam also increased, but some revenue was offset by foreign exchange fluctuations. \"The revenue growth reflects that the group's core business continues to maintain growth momentum, and also demonstrates the progress made by the group in advancing its long-term transformation towards becoming a leading integrated healthcare platform in Southeast Asia.\" The group remains in a loss position, attributed to higher expenses related to digital transformation, marketing activities, depreciation, and amortization"
datetime: "2026-02-11T11:07:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275593622.md)
  - [en](https://longbridge.com/en/news/275593622.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275593622.md)
---

# In the first half of the year, Kangsheng Medical Group's losses narrowed to 10.25 million yuan | Lianhe Zaobao

Thomson Medical Group reported a loss of SGD 10.25 million in the first half of the 2026 fiscal year, a decrease from the SGD 12.90 million loss in the previous year. At the same time, revenue increased by 7% year-on-year to SGD 21.308 million.

The group released its earnings report after the market closed on Wednesday (February 11), indicating that the revenue growth was mainly due to increased income from its Singapore operations and contributions from its Malaysia oncology center. During this period, the number of consultations in Vietnam also increased, but some revenue was offset by foreign exchange fluctuations.

"The revenue growth reflects that the group's core business continues to maintain growth momentum, and also demonstrates the progress the group has made in advancing its long-term transformation towards becoming a leading integrated healthcare platform in Southeast Asia."

The group remains in a loss position, attributed to high expenses related to digital transformation, marketing activities, depreciation, and amortization.

#### Further Reading

Thomson Medical Group to Increase Investment in Vietnam to Deepen Regional Layout Thomson Medical Announces Specific Compensation for the First Time, Executive Vice Chairman Lin Weijie’s Total Compensation for Last Fiscal Year was SGD 967,000

"Although the group is still in a net loss position, the loss has narrowed, reflecting a decline in financial costs and stable operational performance."

Looking ahead, the group will continue to focus on revenue growth and enhance the execution capabilities of its hospitals and specialty platforms.

On Wednesday, the group rose 1.64% to SGD 0.062

### Related Stocks

- [A50.SG](https://longbridge.com/en/quote/A50.SG.md)

## Related News & Research

- [Việt Nam eyes balanced, sustainable trade ties with US](https://longbridge.com/en/news/286951723.md)
- [How to Read the COT Report to Track Forex Market Sentiment](https://longbridge.com/en/news/286848676.md)
- [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md)
- [UAE among first globally to approve new obesity, hypertension treatments](https://longbridge.com/en/news/286707352.md)
- [China retail giant Meiyijia has task cut out in Vietnam’s competitive retail market](https://longbridge.com/en/news/286978968.md)